日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes: The GRADE Randomized Clinical Trial

降血糖药物、血糖和认知结果:GRADE随机临床试验

Luchsinger, José A; Rosin, Samuel P; Kazemi, Erin J; Younes, Naji; Suratt, Colleen E; Fattaleh, Basma N; Florez, Hermes J; Gonzalez, Jeffrey S; Hollander, Priscilla; Hox, Sophia H; Kuo, Shihchen; Lee, Melissa S; Martens, Thomas; Pop-Busui, Rodica; Seaquist, Elizabeth R; Waltje, Andrea H; Barzilay, Joshua I

Temporal and subgroup disparities in mediation effects on cardiovascular outcomes with liraglutide and semaglutide: a post-hoc analysis of LEADER and SUSTAIN-6 trials

利拉鲁肽和索玛鲁肽对心血管结局的中介效应存在时间和亚组差异:LEADER 和 SUSTAIN-6 试验的事后分析

Peng, Zi-Yang; Lee, Yu-Hsuan; Ou, Huang-Tz; Kuo, Shihchen

A comment on "Metformin in the Diabetes Prevention Program 3-year trial: The cost-effectiveness that never was"

对“糖尿病预防计划3年试验中的二甲双胍:从未实现的成本效益”的评论

Herman, William H; Kuo, Shihchen; Zhang, Ping

Can a vegan diet help people with type 1 diabetes save on insulin? A secondary analysis of a 12-Week randomized clinical trial

纯素饮食能否帮助 1 型糖尿病患者减少胰岛素用量?一项为期 12 周的随机临床试验的二次分析

Kahleova, Hana; Maracine, Cristina; Znayenko-Miller, Tatiana; Kuo, Shihchen; Herman, William H; Holubkov, Richard; Barnard, Neal D

Cost-effectiveness of the National Diabetes Prevention Program: A Real-world, 2-Year Prospective Study

国家糖尿病预防计划的成本效益:一项真实世界的为期两年的前瞻性研究

Kuo, Shihchen; Ye, Wen; Wang, Di; McEwen, Laura N; Villatoro Santos, Claudia; Herman, William H

Is Screening for Heart Failure and Peripheral Artery Disease Warranted in Asymptomatic Adults With Diabetes? A Perspective on the 2025 American Diabetes Association "Standards of Care in Diabetes"

对无症状糖尿病成人进行心力衰竭和外周动脉疾病筛查是否必要?基于2025年美国糖尿病协会《糖尿病护理标准》的展望

Herman, William H; Kuo, Shihchen

Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study

对一项随机临床试验的长期随访分析(该试验存在偏离指定治疗的情况):评估二甲双胍对糖尿病及其并发症在糖尿病预防计划结果研究中的影响

Knowler, William C; Pan, Qing; Shu, Shiyu; Tripputi, Mark T; Dabelea, Dana; Edelstein, Sharon L; Kahn, Steven E; Kuo, Shihchen; Luchsinger, José A; Shah, Vallabh; Wallia, Amisha; Temprosa, Marinella

Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program

真实世界干预措施预防2型糖尿病(REALITY):一项评估国家糖尿病预防计划有效性和成本效益的多中心研究

Herman, William H; Tyndall, Benjamin D; Duru, O Kenrik; Moin, Tannaz; McEwen, Laura N; Shao, Hui; Ackermann, Ronald T; Jacobs, Sara R; Neuwahl, Simon; Kuo, Shihchen; Zhang, Ping; Pavkov, Meda E; Villatoro Santos, Claudia

Adaptation of risk prediction equations for cardiovascular outcomes among patients with type 2 diabetes in real-world settings: a cross-institutional study using common data model approach

在真实世界环境中,针对2型糖尿病患者心血管结局风险预测方程的调整:一项采用通用数据模型方法的跨机构研究

Yang, Chun-Ting; Chong, Kah Suan; Wang, Chi-Chuan; Ou, Huang-Tz; Kuo, Shihchen

Longitudinal economic burden of incident complications among metabolic syndrome populations

代谢综合征人群并发症的长期经济负担

Chong, Kah Suan; Chang, Yi-Hsin; Yang, Chun-Ting; Chou, Chu-Kuang; Ou, Huang-Tz; Kuo, Shihchen